Works matching IS 14741776 AND DT 2010 AND VI 9 AND IP 4
Results: 24
Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers.
- Published in:
- 2010
- By:
- Publication type:
- journal article
NIH encourages translational collaboration with industry.
- Published in:
- 2010
- By:
- Publication type:
- Proceeding
The safety and side effects of monoclonal antibodies.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Carbohydrate vaccines: developing sweet solutions to sticky situations?
- Published in:
- 2010
- By:
- Publication type:
- journal article
The anticonvulsants market.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Targeting Toll-like receptors: emerging therapeutics?
- Published in:
- 2010
- By:
- Publication type:
- journal article
Virtual screening: an endless staircase?
- Published in:
- 2010
- By:
- Publication type:
- journal article
Osteoporosis: Serotonin biosynthesis block builds bone.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Anticancer drug development: the grand challenges.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 4, p. 253, doi. 10.1038/nrd3144
- By:
- Publication type:
- Article
Antibacterials: New strategy to target Pseudomonas.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Drug screening: Shifting energy metabolism.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Clinical pharmacology.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 4, p. 339, doi. 10.1038/nrd3147
- Publication type:
- Article
Liraglutide.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Trial watch: NeuroSearch's dopaminergic stabilizer improves movement disorders in Huntington's disease.
- Published in:
- 2010
- Publication type:
- journal article
Trial watch: Phase III success for novel Clostridium difficile antibiotic.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 4, p. 260, doi. 10.1038/nrd3150
- Publication type:
- Article
Market watch: : Key clinical and regulatory events in Q2 2010.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 4, p. 261, doi. 10.1038/nrd3151
- By:
- Publication type:
- Article
Anticancer drugs: A double strike at kinases.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Anticancer drugs: RAF complexities spark caution.
- Published in:
- 2010
- By:
- Publication type:
- journal article
In brief.
- Published in:
- 2010
- Publication type:
- Abstract
Kinase inhibitors attract attention as oral rheumatoid arthritis drugs.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 4, p. 257, doi. 10.1038/nrd3155
- By:
- Publication type:
- Article
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 4, p. 259, doi. 10.1038/nrd3156
- Publication type:
- Article
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 4, p. 262, doi. 10.1038/nrd3157
- By:
- Publication type:
- Article
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 4, p. 251, doi. 10.1038/nrd3159
- Publication type:
- Article
Margaret Anderson.
- Published in:
- 2010
- Publication type:
- Interview